Vincent Chang is an accomplished financial professional with extensive experience in healthcare and biotechnology investments. Currently serving as an Analyst at Millennium since June 2024, Vincent focuses on healthcare long/short equity strategies. Prior experience includes roles at Vivo Capital, where responsibilities involved public equity investments in healthcare and biotech across APAC and global markets, and at ORI Capital Limited, specializing in private equity and venture capital in the healthcare sector. Vincent's background also features investment banking experience at HSBC Global Banking and Markets, with a focus on mergers and acquisitions. Educational credentials include a Bachelor of Science in Finance and a Bachelor of Applied Science in Biomedical Science from The Wharton School and the University of Pennsylvania, respectively, as well as a Master of Science in Biotechnology from The Johns Hopkins University.